Trials / Sponsors / Jennifer Lee Caswell-Jin
Jennifer Lee Caswell-Jin
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer | Phase 2 | 2023-03-20 |
| Terminated | Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer | Phase 1 | 2020-10-13 |